Peptide Therapy: What’s Real, What’s Hype, and What We Recommend at Ikigai

Peptide therapy has become one of the most talked-about topics in longevity, biohacking, and wellness medicine. From podcasts and social media to high-end “anti-aging” clinics, peptides are often promoted as tools for faster healing, better sleep, improved cognition, fat loss, and even longevity.

A recent New York Times article (paywall) highlighted the rapid rise of off-label and non-FDA-approved peptide use, particularly in tech and wellness circles. Since then, we’ve received a growing number of questions from patients asking whether peptides are safe, effective, or something they should be considering.


In This Article


What Are Peptides?

Peptides are short chains of amino acids—the same building blocks that make up proteins. In the human body, peptides play important roles in hormone signaling, metabolism, immune regulation, and cellular communication.

Some peptide-based therapies are legitimate, rigorously studied medications. The most well-known example is the GLP-1 class of drugs used for diabetes and weight loss, which are among the most extensively researched medications in modern medicine.

The confusion arises when the success of one peptide class is extrapolated to many others that are not FDA-approved and are not supported by high-quality human evidence.

Why Peptide Therapy Is Trending Now

Interest in peptide injections and peptide therapy has surged for several reasons:

  • Increased focus on longevity and healthspan optimization

  • Frustration with slow or fragmented traditional medical care

  • High-profile promotion by wellness influencers and celebrities

  • Anecdotal success stories shared online

  • The proven impact of GLP-1 medications, which reshaped expectations

While this enthusiasm is understandable, popularity alone does not establish safety or effectiveness.

The Evidence Gap in Most Peptide Use

Most peptides currently marketed for injury recovery, muscle growth, fat loss, sleep improvement, cognitive enhancement, or “anti-aging” share a central limitation: human evidence is sparse or absent.

Many have shown promise in animal models or laboratory studies. However, history has repeatedly shown that encouraging preclinical results often fail to translate into meaningful clinical benefit in humans.

For many peptides, we still lack:

  • Randomized, placebo-controlled human trials

  • Clear clinical indications

  • Established dosing, frequency, and duration

  • Long-term safety data

Without this information, it becomes difficult to responsibly weigh benefit against risk.

Real Risks of Non-FDA-Approved Peptides

When people think about peptide safety, they often focus on side effects like injection-site irritation. In reality, the more significant risks occur earlier and are less visible.

Quality and Sterility Concerns

Many peptides are obtained through compounding pharmacies or online vendors and are often labeled “for research use only.” These products have not undergone the same manufacturing oversight required for FDA-approved medications. Variability in purity, sterility, and concentration is a legitimate concern.

Unknown Dosing and Long-Term Effects

Without robust clinical trials, there is no reliable way to determine the correct dose—or whether the doses promoted online are safe. Long-term effects are largely unknown, particularly for peptides that influence growth, hormones, or blood vessel formation.

Regulatory and Medicolegal Uncertainty

The use of non-approved injectable therapies places both patients and clinicians in uncertain territory, medically and legally. This matters, especially when safer, evidence-based alternatives exist.

Peptides and Athletic or Performance Use

Several peptides commonly marketed for recovery or performance enhancement are prohibited in competitive sports. Even recreational athletes should be aware that these restrictions may apply to amateur competitions, professional organizations, or employer-based testing programs.

The Ikigai Approach to Peptide Therapy

At Ikigai Health Institute, our approach is consistent across all interventions.

Low risk. Clear rationale. Measurable benefit.

Before recommending any therapy—peptide or otherwise—we ask:

  1. Is there solid human evidence supporting this use?

  2. Is the product regulated and reliably manufactured?

  3. Can we clearly define the goal and objectively measure outcomes?

  4. Do we understand the short- and long-term risks?

For most peptides currently marketed for longevity, wellness, or performance, at least one of these questions remains unanswered.

That doesn’t mean peptides will never have a role. Some may ultimately prove beneficial. But at present, broad use has clearly outpaced scientific validation.

What We Prioritize Instead

Patients interested in peptide therapy are usually trying to improve one or more of the following:

  • Recovery from injury or training

  • Sleep quality and fatigue

  • Body composition and metabolic health

  • Focus, energy, or cognitive performance

In most cases, we can achieve meaningful progress through lower-risk, evidence-based strategies, including optimized training, nutrition, sleep physiology, stress management, and—when appropriate—well-studied medications with known safety profiles.

These approaches may be less trendy, but they are far more likely to produce durable benefits without unintended consequences.

Bottom Line: Are Peptides Worth Considering?

Peptides are not inherently dangerous, and some peptide-based therapies have transformed modern medicine. However, the current peptide craze represents an unregulated therapeutic frontier where patient demand has moved faster than the science.

Until stronger human data exist and quality concerns are resolved, most peptides being promoted for anti-aging, healing, or cognitive enhancement do not meet our standard for routine use.

If you’re considering peptide therapy—or already using peptides—and want an evidence-based perspective tailored to your goals, we encourage you to discuss it with us. Our role is not to dismiss new ideas, but to help you make decisions grounded in science and aligned with long-term health.

Next
Next

HDL: What It Is, What It Isn’t, and What We Still Don’t Know